Skip to content

Welcome to Discover Pharma! Today is : November 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Cancer immunotherapy

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Enterome’s EO2463 receives FDA fast track designation for follicular lymphoma watch-and-wait treatment

    Enterome has received Fast Track designation from the US Food [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg secures free supply of bispecific antibody for POLB 001 trial at The Christie

    Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Strand Therapeutics appoints Jason Luke as chief medical officer

    Strand Therapeutics has appointed oncology researcher Jason Luke as its [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Mabion manufactures first batch of NovalGen’s bispecific T-cell engager for clinical trials

    Poland-based CDMO Mabion has completed the first GMP-compliant batch of [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Enterome secures $19M to progress OncoMimics immunotherapy in indolent non-Hodgkin lymphoma

    Funding to advance EO2463 through Phase 1/2 and prepare for [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Commit Biologics launches Scientific Advisory Board to accelerate BiCE platform development

    Commit Biologics has announced the formation of a Scientific Advisory [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events

    Poolbeg receives FDA Orphan Drug Designation for POLB 001

    Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]

    May 5, 2026
  • Drug Discovery & Development

    SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges

    SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

    May 5, 2026
  • Biotech & Pharma Business

    Immunai and Parker Institute partner on landmark single-cell cancer dataset

    May 5, 2026
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Ryvu reports preclinical results for novel ADC payload
    Categories: Drug Discovery & Development, Research & Development
  • Kindeva wins $226 million contract for nerve agent antidote autoinjectors
    Categories: Manufacturing & Supply Chain
  • Nabsys launches RepX for repeat expansion analysis
    Categories: Genomics and sequencing
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top